Merck & Company Inc (MRK)vsUtah Medical Products Inc (UTMD)
MRK
Merck & Company Inc
$146.35
+3.85%
HEALTHCARE · Cap: $360.08B
UTMD
Utah Medical Products Inc
$68.84
-5.78%
HEALTHCARE · Cap: $231.97M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 190544% more annual revenue ($66.57B vs $34.92M). UTMD leads profitability with a 30.5% profit margin vs 4.8%. MRK appears more attractively valued with a PEG of 2.71. UTMD earns a higher WallStSmart Score of 54/100 (C-).
MRK
Hold36
out of 100
Grade: F
UTMD
Buy54
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$83.64
Current Price
$146.35
$62.71 premium
Margin of Safety
-49.3%
Fair Value
$42.70
Current Price
$68.84
$26.14 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Keeps 31 of every $100 in revenue as profit
Strong operational efficiency at 34.8%
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Areas to Watch
Trading at 8.6x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
Revenue declined 12.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : UTMD
The strongest argument for UTMD centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 30.5% and operating margin at 34.8%.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 115.8x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : UTMD
The primary concerns for UTMD are Market Cap, Piotroski F-Score, PEG Ratio.
Key Dynamics to Monitor
MRK profiles as a value stock while UTMD is a declining play — different risk/reward profiles.
UTMD carries more volatility with a beta of 0.39 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
UTMD scores higher overall (54/100 vs 36/100), backed by strong 30.5% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Utah Medical Products Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?